<DOC>
	<DOCNO>NCT01298505</DOCNO>
	<brief_summary>The purpose study healthy people investigate safety , toleration time course PF-03654764 blood , follow multiple dos give mouth together fexofenadine .</brief_summary>
	<brief_title>A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Terfenadine</mesh_term>
	<criteria>Healthy subject . ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . A positive urine drug screen . Treatment investigational drug within 30 day ( determined local requirement , whichever long ) 5 halflives precede first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Phase 1 multiple dose safety toleration fexofenadine</keyword>
</DOC>